Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Approach Anatomic Site Code	NCIT_C93507	[A coded value specifying the anatomic location or access point for a procedure.]
CTDSP2 wt Allele	NCIT_C54380	[Human CTDSP2 wild-type allele is located within 12q13-q15 and is approximately 27 kb in length. This allele, which encodes carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2, plays a role in the hydrolysis of phosphoproteins.]
CTDSP2 Gene	NCIT_C24651	[This gene plays a role in the transcription and processing of pre-mRNA.]
Stage IV Ovarian Cancer AJCC v6 and v7	NCIT_C7832	[Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)]
General Factor Contributing To Drug Interaction	NCIT_C54381
Recurrent Ovarian Carcinoma	NCIT_C7833	[The reemergence of ovarian carcinoma after a period of remission.]
Ovarian Carcinoma	NCIT_C4908	[A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women. It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups. Adenocarcinomas constitute the vast majority of ovarian carcinomas. The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type. The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver. Lung and pleura are the most common sites of extra-abdominal spread. The primary form of therapy is surgical. The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.]
BRCATA wt Allele	NCIT_C54382	[Human BRCATA is located in the vicinity of 11q23 and the length is currently undetermined. This gene, which encodes Breast cancer, 11;22 translocation associated protein, may play a role in tumor pathogenesis.]
Recurrent Childhood Brain Neoplasm	NCIT_C7834	[The reemergence of brain neoplasm in childhood after a period of remission.]
Childhood Brain Neoplasm	NCIT_C7703	[A benign or malignant, primary or metastatic neoplasm of the brain occurring in children.]
Recurrent Childhood Central Nervous System Neoplasm	NCIT_C9045	[The reemergence of central nervous system neoplasm in childhood after a period of remission.]
Type Of Drug Interaction Consequence	NCIT_C54383	[A category of results of drug adverse reaction or drug interaction.]
Type of Event	NCIT_C53053	[A particular category of events regarded as having particular characteristics, qualities, and/or defined similarities.]
Localized Resectable Neuroblastoma	NCIT_C7835	[A neuroblastoma which is confined to a specific site and is amenable to surgical removal.]
Resectable Neuroblastoma	NCIT_C150620	[Neuroblastoma that is amenable to surgical resection.]
Localized Primitive Neuroectodermal Tumor	NCIT_C27294	[A primitive neuroectodermal tumor that has not spread to other anatomic sites.]
BRCD1 wt Allele	NCIT_C54384	[Human BRCD1 wild-type allele is located in the vicinity of chromosome 13 and the length of the gene is currently unknown. This allele, which encodes breast cancer, ductal, suppressor-1 protein, is involved in tumor suppression. Variant alleles are associated with several types of cancers; including, retinoblastoma, mesenchymal tumors and ductal carcinoma.]
LRRC17 wt Allele	NCIT_C54385	[Human LRRC17 wild-type allele is located in the vicinity of 7q22.1 and is approximately 32 kb in length. This allele, which encodes leucine-rich repeat-containing protein 17, is putatively involved in cell differentiation.]
LRRC17 Gene	NCIT_C24653	[This gene may play a role in cell differentiation.]
Pharmacokinetic Effect	NCIT_C54386	[Processes that effect the level of a drug in the body.]